Pharma

As the healthcare sector evolves at speed, pharma needs an improved framework to guide its marketing effort and answer the eternal business questions: who to target and how.

Understanding why real-world treatment in oncology can be sub-optimal – and what can be done about it.

The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.

How have the Point of Care (PoC) and rapid testing markets evolved over the past two years? What are the key challenges, unmet needs and opportunities for companies working in POC & rapid testing today?

2021 put the spotlight firmly on pharmaceutical companies, whose image has been enhanced by the leading role they have played in combating the pandemic. Confidence indicators in the industry itself, as well as in pharmaceutical products and vaccines in general, are on the rise, but cannot conceal structural image issues for the sector as a whole, as is the case with combating shortages or the pursuit of the public interest.

How has the Point of Care (PoC) and rapid testing market evolved, and what does the future hold? What are the key challenges, unmet needs and opportunities for companies working in PoC & rapid testing today?

Affordability, Evidence & Value Attribution

The ongoing pandemic has placed the pharmaceutical industry in the spotlight like never before. Alongside the fight against COVID-19, effectively communicating with stakeholders is more important than ever.

Optimising pharma-HCP communications post COVID-19.